The nanotechnology developed by University of Queensland scientists can detect and monitor extracellular vesicles (EVs) in the bloodstream.
Computed tomography (CT) of the chest demonstrates better sensitivity than reverse-transcription polymerase chain reaction (RT‑PCR) when it comes to diagnosing COVID‑19.
The test will detect the infection early in blood by embedding monoclonal antibodies against surface glycoproteins (GP) — one of the first detectable biomarkers of infection.
An international team of researchers has found that methane emissions from human fossil sources are at least 25% higher than previously estimated.
Two particularly tenacious species of bacteria have colonised the potable water dispenser aboard the International Space Station.
CSIRO has developed a new technology that pulls CO2 out of the atmosphere and puts it into beer and other beverages.
Researchers have developed a new technology for removing oil from water sources, creating textiles with surface properties that passively skim off the oil and move it into a floating container.
The abundant base metal chromium can substitute expensive precious metals in photocatalysis — a technique currently used to synthesise pharmaceuticals and fine chemicals.
The sound of a 3000-year-old mummified Egyptian priest has been reproduced based on measurements of the precise dimensions of his extant vocal tract following CT scanning.
Over 50 different studies show links between human-induced climate change and increased frequency or severity of fire weather.
A novel non-invasive technique can successfully detect human papilloma virus-16 — the strain associated with oropharyngeal cancer — in saliva samples.
Starquakes recorded by NASA's now-defunct Kepler space telescope have helped answer a longstanding question about the age of the 'thick disc' of the Milky Way.
A new rapid test is expected to return a finding after just 60 to 90 min — and all it requires to diagnose asthma is a drop of blood and the immune cells it contains.
The urine test diagnoses aggressive prostate cancer and predicts whether patients will require treatment up to five years earlier than standard clinical methods.